Follow-The-Filings

Security

ACAD

Acadia Pharmaceuticals Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

15 owners 1 new max 0.1% (Steve Cohen - Point72 Ass...)

grid → activity →
owners 15
max % 0.1%
tracked value $660M
qoq N 1 A 6 R 6

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.1% Reduce -0.03 pp 2,577,916 $57M hist
Renaissance Technologies LLC 2026 Q1 0.1% Add 0.00 pp 1,724,196 $38M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.04 pp 1,119,117 $30M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 15,153,957 $405M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 732,872 $16M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce -0.01 pp 729,836 $16M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 705,461 $16M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Reduce 0.00 pp 527,913 $12M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% New 0.0% 312,982 $7M hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.0% Add 0.00 pp 141,812 $3M hist
Norges Bank 2025 Q4 stale 0.0% Exit 0.00 pp 1,507,527 $40M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 622,760 $14M hist
Natixis Advisors, LLC 2026 Q1 0.0% Add 0.00 pp 100,399 $2M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce -0.01 pp 76,187 $2M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 40,358 $898 hist

15 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $726.44M $957.8M $1.07B
Gross profit * $116.8M $875.96M $982.51M
Gross margin * 16.1% 91.5% 91.7%
Net income -$43.02M $226.45M $391M
Net margin * -5.9% 23.6% 36.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $616.12M $938.32M $1.06B
Total non-current assets * $132.83M $249.44M $502.08M
Total assets $748.96M $1.19B $1.56B
Total current liabilities $254.25M $394.87M $277.11M
Total non-current liabilities * $62.95M $60.09M $59.69M
Total equity $431.76M $732.79M $1.23B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $16.7M $157.72M $109.84M
Cash from investing $32M -$30.54M -$302.56M
Cash from financing $25.13M $6.84M $49.88M
Net change in cash $73.81M $133.93M -$142.82M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders